Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E11.01 EPS (ttm)2.81 Insider Own0.03% Shs Outstand5.90B Perf Week6.51%
Market Cap182.35B Forward P/E9.94 EPS next Y3.11 Insider Trans0.05% Shs Float5.55B Perf Month-9.38%
Income15.95B PEG18.35 EPS next Q0.73 Inst Own73.70% Short Float0.97% Perf Quarter-21.53%
Sales51.75B P/S3.52 EPS this Y62.30% Inst Trans0.52% Short Ratio1.69 Perf Half Y-13.64%
Book/sh11.27 P/B2.74 EPS next Y7.06% ROA10.00% Target Price42.07 Perf Year-26.93%
Cash/sh1.67 P/C18.55 EPS next 5Y0.60% ROE26.40% 52W Range27.88 - 44.56 Perf YTD-21.13%
Dividend1.52 P/FCF76.98 EPS past 5Y14.70% ROI14.70% 52W High-30.66% Beta0.52
Dividend %4.92% Quick Ratio0.70 Sales past 5Y0.90% Gross Margin80.70% 52W Low10.83% ATR1.77
Employees88300 Current Ratio0.90 Sales Q/Q-9.20% Oper. Margin31.50% RSI (14)44.31 Volatility5.32% 5.73%
OptionableYes Debt/Eq0.83 EPS Q/Q42.90% Profit Margin31.40% Rel Volume1.14 Prev Close31.75
ShortableYes LT Debt/Eq0.57 EarningsApr 28 BMO Payout49.30% Avg Volume31.79M Price30.90
Recom2.50 SMA20-4.42% SMA50-13.10% SMA200-18.13% Volume36,097,724 Change-2.68%
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Mar-27-20 06:45PM  Covid-19 Could Benefit Generic Drug Companies GuruFocus.com
04:16PM  Drug makers on shaky ground as clinical trials are postponed and drug launches delayed amid pandemic MarketWatch
10:27AM  Coronavirus Means Fewer Stock Buybacks, Analyst Says. It Could Shake Up Biopharma. Barrons.com
10:20AM  Pfizer Completes $1.25 Billion Sustainability Bond for Social and Environmental Impact Business Wire
09:10AM  Pfizer and Mylan Postpone Upjohn Deal. Analysts Arent Worried. Barrons.com
08:57AM  Zacks Value Trader Highlights: eBay, Pfizer, JPMorgan Chase, Intuitive Surgical and Edwards Lifesciences Zacks
08:14AM  Drugmaker Vertex to delay new clinical studies due to coronavirus Reuters
05:31AM  Pfizer Stock Falls 3% Investing.com
Mar-26-20 01:13PM  5 Superstar Stocks on Sale During the Coronavirus Crisis Zacks +6.72%
01:04PM  Pfizer's Upjohn Combo With Mylan Is Delayed What That Means For PFE Stock Investor's Business Daily
11:15AM  This portfolio manager draws on 2008 lessons to find stocks that will outlast a pandemic MarketWatch
09:50AM  Pfizer Stock Rises 5% Investing.com
09:20AM  $110M injection powers up Peninsula vaccine maker but not for COVID-19 American City Business Journals
08:23AM  The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer's Upjohn-Mylan Merger Benzinga
07:22AM  Mylan delays merger with Upjohn due to COVID-19 pandemic American City Business Journals
07:01AM  Drugmakers Mylan, Pfizer delay merger due to coronavirus outbreak Reuters
06:57AM  Drugmakers Mylan, Pfizer delay merger due to coronavirus outbreak Reuters
06:45AM  Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn PR Newswire
06:45AM  Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn Business Wire
Mar-25-20 05:45PM  Pfizer (PFE) Gains But Lags Market: What You Should Know Zacks
01:07PM  Pfizer pauses new studies due to coronavirus Reuters
11:20AM  Pfizer Inc. -- Moody's assigns A1 to Pfizer's notes, on review for downgrade Moody's
10:08AM  Pfizer's Eczema Drug Eucrisa Gets FDA Approval for Infants Zacks
10:00AM  Pfizer Is Entering The Coronavirus Drug Hunt But Is PFE Stock A Buy? Investor's Business Daily
09:49AM  Pfizer Stock Rises 3% Investing.com
Mar-24-20 05:35PM  Peninsula biotech scores $80M upfront in potential $1.6 billion cancer drug deal American City Business Journals
10:00AM  Is AbbVie Stock A Buy As Coronavirus Worries Hammer The Market? Investor's Business Daily
06:45AM  U.S. FDA Approves Supplemental New Drug Application (sNDA) for Expanded Indication of EUCRISA® (Crisaborole) Ointment, 2%, in Children as Young as 3 Months of Age With Mild-to-Moderate Atopic Dermatitis Business Wire
Mar-23-20 09:15AM  The Zacks Analyst Blog Highlights: Pfizer, Roche, Sanofi, Lilly and Merck Zacks
09:12AM  The Zacks Analyst Blog Highlights: Macy's, AbbVie, Pfizer and New Residential Investment Zacks
Mar-20-20 04:34PM  Covid Report: How A Blockbuster Pfizer Drug Benefits From Coronavirus Investor's Business Daily
10:52AM  Pharma Stock Roundup: SNY, RHHBY, PFE's Coronavirus Product Development & Other Updates Zacks
10:42AM  4 Dividend Stocks to Buy Amid the Coronavirus Rout Zacks
09:45AM  Dow falls nearly 150 points on losses in shares of Goldman Sachs, Exxon Mobil MarketWatch
09:40AM  Does ibuprofen make the coronavirus worse? Is it still safe to take aspirin? MarketWatch
09:25AM  Health Canada okays GSK unit's monthly HIV injection Reuters
05:40AM  Pfizer Stock Falls 3% Investing.com
Mar-19-20 10:05AM  Pfizer's Eczema Drug & Pneumococcal Vaccine Succeed in Study Zacks -6.00%
07:37AM  The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection Benzinga
Mar-18-20 05:45PM  Pfizer (PFE) Gains As Market Dips: What You Should Know Zacks
04:51PM  Pfizer puts off investor day, reports two late-stage study results in advance Reuters
04:25PM  Pfizer Postpones Investor Day Scheduled for March 31, 2020 Due to Coronavirus Concerns Business Wire
04:24PM  Pharmaceutical Companies Gain in the Fight Against Covid-19 GuruFocus.com
04:15PM  Pfizer Announces Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults Aged 18 Years or Older Business Wire
04:15PM  Pfizer Announces Positive Top-Line Results from Third Phase 3 Trial of Abrocitinib for Moderate to Severe Atopic Dermatitis, Which Showed Improvements in Skin Clearance, Disease Extent and Severity, and Itch Business Wire
04:11PM  Pfizer indicates it will tap Boulder facility for help developing coronavirus vaccine American City Business Journals
11:35AM  Merck's Chronic Cough Candidate Achieves Goals in Phase III Zacks
10:57AM  Pfizer, Regeneron Give Update on Coronavirus Drug Development Zacks
09:30AM  Company News for Mar 18, 2020 Zacks
06:00AM  IDEAYA and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Binimetinib in Solid Tumors Harboring GNAQ or GNA11 Hotspot Mutations PR Newswire
05:33AM  Pfizer Stock Falls 3% Investing.com
Mar-17-20 06:09PM  US STOCKS-Wall St jumps after Monday's historic sell-off as Fed boosts liquidity to fight coronavirus effect Reuters +6.56%
05:33PM  US STOCKS-Wall St bounces after Monday's historic sell-off as Fed boosts liquidity to fight coronavirus effect Reuters
05:13PM  Covid Report: Biotech IPO Breaks Out On Pfizer Deal For Coronavirus Drug Investor's Business Daily
12:44PM  US STOCKS-Wall St rebounds from Monday's crash as Fed boosts liquidity Reuters
11:02AM  Moderna Up as First Human Trial of Coronavirus Vaccine Begins Zacks
10:36AM  US STOCKS-Wall St dips again after biggest rout since 1987 Reuters
10:00AM  Pfizer Invites Public to View and Listen to Webcast of April 28 Conference Call with Analysts Business Wire
09:45AM  UnitedHealth, Procter & Gamble share gains contribute to Dow's 89-point climb MarketWatch
09:17AM  Pfizer and BioNTech Are Teaming Up to Develop a Coronavirus Vaccine Barrons.com
08:09AM  BioNTech, Pfizer to develop COVID-19 vaccine candidate MarketWatch
05:17AM  MORNING BID-Borders and pubs are shutting. What about markets? Reuters
02:06AM  Pfizer, BioNTech to co-develop potential coronavirus vaccine Reuters
02:02AM  Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine GlobeNewswire
02:00AM  Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine Business Wire
Mar-16-20 09:47AM  Pfizer (PFE) Catches Eye: Stock Jumps 9% Zacks -7.73%
07:45AM  Who Has Been Buying Pfizer Inc. (NYSE:PFE) Shares? Simply Wall St.
05:33AM  Pfizer Stock Falls 8% Investing.com
Mar-13-20 03:53PM  Germany's CureVac says low-dose coronavirus vaccine could allow for mass production Reuters +8.96%
03:25PM  Pfizer Outlines Five-Point Plan to Battle COVID-19 Business Wire
08:00AM  Merck and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study PR Newswire
08:00AM  EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study PR Newswire
05:32AM  Pfizer Stock Rises 3% Investing.com
Mar-12-20 01:25PM  How to invest when the coronavirus pandemic and Trump send the Dow crashing: experts Yahoo Finance -6.68%
08:30AM  No Bottom Yet for Pfizer's Charts but We Have Price Targets to Watch TheStreet.com
04:52AM  Trump announces coronavirus travel ban on Europe, Dow futures plummet Yahoo Finance
Mar-11-20 01:55PM  Dow's 1250-point fall led by losses in shares of Boeing, Dow Inc. MarketWatch -7.00%
01:52PM  Boeing, Dow Inc. share losses lead Dow's 1,263-point drop MarketWatch
07:00AM  INSIGHT-As pressure for coronavirus vaccine mounts, scientists debate risks of accelerated testing Reuters
Mar-10-20 05:13PM  3 Sectors Holding Up Well Despite Market Selloffs GuruFocus.com
06:49AM  Watchdog told to review evidence against Pfizer and Flynn Financial Times
Mar-09-20 02:27PM  Trump, White House officials to discuss economic response to coronavirus: Rpt Yahoo Finance Video
11:13AM  GSK's HIV combo treatment meets main goal in late-stage study Reuters
09:43AM  Mylan-Upjohn Merger in Focus, Coronavirus Might Hit Supply Zacks
Mar-08-20 01:10PM  Should You Buy Pfizer Inc. (PFE)? Insider Monkey
Mar-06-20 02:40PM  Stocks nosedive as coronavirus cases surpass 100K Yahoo Finance Video
01:19PM  Pfizer Wont Win the Coronavirus Pharma War InvestorPlace
10:18AM  Pharma Stock Roundup: Trump, Pharma Executives Meeting on Coronavirus, FDA Updates Zacks
09:50AM  Pfizer Stock Falls 3% Investing.com
07:36AM  The Zacks Analyst Blog Highlights: Walmart, Pfizer, Charter Communications, Lockheed Martin and CME Zacks
Mar-05-20 07:51PM  Pfizer weighs working with BioNTech on potential coronavirus vaccine - R&D head Reuters
02:56PM  Top Stock Reports for Walmart, Pfizer & Charter Communications Zacks
10:12AM  US Indexes Rebound Wednesday With New Stimulus GuruFocus.com
08:12AM  Pfizer Stock Falls 3% Investing.com
08:00AM  Zoetis' First CEO Shows You How To Thrive On Your Own Investor's Business Daily
07:13AM  Biopharma companies race to create coronavirus vaccine Yahoo Finance Video
06:36AM  These stocks soared the most after Biden burned Bernie on Super Tuesday MarketWatch
01:21AM  Merck KGaA forecasts strong profit growth on healthcare, lab gear Reuters
12:00AM  How unlocking the secrets of African DNA could change the world Financial Times
Mar-04-20 04:15PM  Dow Jones Today: Primary Results, Stimulus Speculation Prove Potent InvestorPlace +6.12%
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, such as cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; oncology, such as biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; licensing agreement with Akcea Therapeutics, Inc; strategic alliance with Verily Life Sciences LLC; collaboration agreement with Merck KGaA; and clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PFIZER INC10% OwnerMar 16Buy16.00312,5005,000,0001,481,719Mar 16 07:15 PM
GOETTLER MICHAELGroup PresidentFeb 28Option Exercise27.3722,852625,45953,036Mar 03 12:54 PM
JOHNSON RADY AExecutive Vice PresidentFeb 28Option Exercise27.3715,996437,81187,956Mar 03 12:54 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 28Option Exercise27.3738,8481,063,270172,542Mar 03 12:54 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 28Option Exercise27.3737,9341,038,254140,256Mar 03 12:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 28Option Exercise27.3717,824487,84330,045Mar 03 12:54 PM
SUSMAN SALLYExecutive Vice PresidentFeb 28Option Exercise27.3791,4082,501,837222,496Mar 03 12:55 PM
YOUNG JOHN DGroup PresidentFeb 28Option Exercise27.37100,5482,751,999504,427Mar 03 12:55 PM
BOURLA ALBERTChairman & CEOFeb 28Option Exercise27.3733,135906,905232,888Mar 03 12:49 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 28Option Exercise27.3727,422750,540140,744Mar 03 12:49 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 28Option Exercise27.37173,6754,753,485556,084Mar 03 12:49 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise34.59144,9285,013,060503,738Feb 28 07:32 PM
ROGERS DAWNExecutive Vice PresidentFeb 26Option Exercise34.5915,097522,20524,995Feb 28 07:28 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise34.5972,4642,506,530180,558Feb 28 07:28 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise34.5933,4141,155,79093,211Feb 28 07:24 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise34.5988,5673,063,533189,936Feb 28 07:25 PM
GOETTLER MICHAELGroup PresidentFeb 26Option Exercise34.5920,129696,26245,557Feb 28 07:22 PM
Hwang AngelaGroup PresidentFeb 26Option Exercise34.5914,493501,31332,470Feb 28 07:22 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise34.59144,9285,013,060482,320Feb 28 07:19 PM
BOURLA ALBERTChairman & CEOFeb 26Option Exercise34.5988,5673,063,533274,479Feb 28 07:16 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise34.5924,155835,521131,196Feb 28 07:15 PM
Gottlieb ScottDirectorJan 30Buy37.001,00036,9974,000Jan 31 08:06 AM
PFIZER INC10% OwnerSep 17Buy18.0050,000900,0004,593,847Sep 19 04:19 PM
Gottlieb ScottDirectorAug 23Buy34.723,000104,1603,000Aug 26 09:27 AM
DAMELIO FRANK AExecutive Vice PresidentJul 02Sale44.09153,1846,753,385337,392Jul 03 04:06 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentJun 20Sale44.0030,0001,320,00080,094Jun 21 04:08 PM
PFIZER INC10% OwnerMay 13Buy17.0050,000850,0003,249,973May 14 07:34 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentApr 01Sale42.8315,000642,503110,094Apr 02 03:05 PM